New Study Finds Psoriasis Patients Favor Oral Treatments Over Injections
SPRING HOUSE, PA — A new U.S. study from Johnson & Johnson (NYSE: JNJ) reveals that most people living with psoriasis — and their healthcare providers — strongly prefer effective …
New Study Finds Psoriasis Patients Favor Oral Treatments Over Injections Read More